A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
Launched by UNIVERSITY OF MINNESOTA · Jan 2, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to help people from BIPOC (Black, Indigenous, and People of Color) communities quit smoking, as they often face more serious health issues related to tobacco use compared to White populations. The study will reach out to BIPOC adults who smoke in two healthcare systems, offering personalized support and resources to help them stop smoking. This proactive approach aims to make it easier for these individuals to access proven treatments for quitting smoking, like medications and counseling, and to ensure they feel welcomed and supported in the healthcare system.
To participate in this study, you need to be 18 years or older, speak English or Spanish, and have been identified as a BIPOC patient who has smoked at least one cigarette in the past month. You also need to have a phone number or address on file with the healthcare system. Throughout the trial, participants can expect to receive ongoing support and resources to help them quit smoking, and the researchers hope that this tailored outreach will lead to better outcomes for those involved. If you have any questions or think you might want to join, don't hesitate to ask your healthcare provider for more information!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English or Spanish-speaking BIPOC patients within the Hennepin Healthcare or MCHS system. BIPOC patients are any patients with a chart identified race that is not White, and will be verified by self-report from the baseline survey.
- • Currently smoke \>1 cigarette over the past 30 days
- • Must have address or telephone number in the electronic health record
- Exclusion Criteria:
- • Electronic health record documented cognitive impairment or legal guardianship
- • Patients who have opted out of reserach studies
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Minneapolis, Minnesota, United States
Rochester, Minnesota, United States
Patients applied
Trial Officials
Steven Fu, MD, MSCE
Principal Investigator
Minneapolis Veterans Affairs Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials